Globestar Therapeutics Corporation (PK) (GSTC) Share Price

That might have worked back in the day.. but doing it today can realllllllly backfire on the ceo

Who here has been told to grab or buy shares? Cause it’s going to be fantastic??? By Jim?

Almost 20+ off hub saying he did

10 cents and I'm buying a TSLA plaid s

this hits $1 Max, this will never be the next Tesla! this is what we are dealing with lol

When do we moooooon !!!!!

huge buying OPP...bid 0008 now....when Jim's ready this moves fast to 005-01

Crazy spread right now. .0006 x .001. It seems like MMs don’t want this thing to trade at all right now.

GlobeStar is focused on efforts to obtain regulatory approvals for, and then commercialize, Project Amethyst™. Project Amethyst™ is a compound intended to treat neurodegeneration from MS, consisting of a patented custom drug cocktail of Minocycline, Fluconazole, and Atorvastatin. Each of these drugs has been approved by the FDA for separate applications. GSTC is the exclusive worldwide licensee for the all patents and patent applications relating to this compound.

GlobeStar is endeavoring to arrange financing to commence a study of the pharmacokinetic action of the three drugs, and then to initiate a clinical trial. Pharmacokinetics looks at changes in a drug after administration. A pharmacokinetic study generally requires from two weeks to eight weeks.

GlobeStar is discussing the parameters for a pharmacokinetic study with several Clinical Research Organizations (CRO's) in Europe and India. The CRO selected by GlobeStar would assist the company, SMI HealthCare LLC (SMIHC) and Advanced Innovative Partners (AIP) to develop a clinical trial plan. GlobeStar intends to seek FDA guidance in the development of that plan.

Following completion of the pharmacokinetic study, GlobeStar intends to arrange financing for SMIHC to manage an initial clinical trial in India, as well as regulatory filings, intellectual property rights filings, manufacturing, sales and distribution in India, Southeast Asia, Africa, and the Middle East. The clinical trial likely would require approximately three to six months. If results are positive, the trial would support regulatory clearance in India and potentially other countries, facilitating the Company's transition to revenues. Results also could be used to accelerate progress toward regulatory approval in the United States, though an additional trial likely would be required to obtain FDA approval.

It is anticipated that AIP will provide advice to GlobeStar and SMIHC on the global design, strategy and execution of clinical trials, regulatory filings, intellectual property rights filings, and manufacturing for Project Amethyst™.

GlobeStar is focused on efforts to obtain regulatory approvals for, and then commercialize, Project Amethyst™. Project Amethyst™ is a compound intended to treat neurodegeneration from MS, consisting of a patented custom drug cocktail of Minocycline, Fluconazole, and Atorvastatin. Each of these drugs has been approved by the FDA for separate applications. GSTC is the exclusive worldwide licensee for the all patents and patent applications relating to this compound.

GlobeStar is endeavoring to arrange financing to commence a study of the pharmacokinetic action of the three drugs, and then to initiate a clinical trial. Pharmacokinetics looks at changes in a drug after administration. A pharmacokinetic study generally requires from two weeks to eight weeks.

GlobeStar is discussing the parameters for a pharmacokinetic study with several Clinical Research Organizations (CRO's) in Europe and India. The CRO selected by GlobeStar would assist the company, SMI HealthCare LLC (SMIHC) and Advanced Innovative Partners (AIP) to develop a clinical trial plan. GlobeStar intends to seek FDA guidance in the development of that plan.

Following completion of the pharmacokinetic study, GlobeStar intends to arrange financing for SMIHC to manage an initial clinical trial in India, as well as regulatory filings, intellectual property rights filings, manufacturing, sales and distribution in India, Southeast Asia, Africa, and the Middle East. The clinical trial likely would require approximately three to six months. If results are positive, the trial would support regulatory clearance in India and potentially other countries, facilitating the Company's transition to revenues. Results also could be used to accelerate progress toward regulatory approval in the United States, though an additional trial likely would be required to obtain FDA approval.

It is anticipated that AIP will provide advice to GlobeStar and SMIHC on the global design, strategy and execution of clinical trials, regulatory filings, intellectual property rights filings, and manufacturing for Project Amethyst™.

0007 another buying OPP...low volume cleanup continues from scared money

waiting on updates...cheap AF here 0007-001 is GIFTS

Trials starting next week!lfgo Jim saved us

It’ll catch up to him

You should hear the lies on his other ticker...
Jim told investors to buy via phone. A lot of people are getting together with what he said Never believe the con, just trade the action.

Easier said than done, I know, but here's the important part:

Never believe the con - believers become bagholderz unfortunately.

You tell me…

Why is GSTC going up? 😁

Jim told investors to buy via phone. A lot of people are getting together with what he said

This is a scam fellas, no reason to think otherwise. There is nothing here but bag holders

Just a reminder.. he (Jim) was openly encouraging people to buy this stock when he can't do such thing.. since then stock tanked even more, so why he is not in prison already and we don't have new CEO ? Fuk jim.. this little rat

Imo used to fund other lies w/ $VXIT.
Jim trying to pump people again when he hasn’t done anything in 4 years.. other than sell on retail… and where did that money go? His other pretend company.

Whatever.

Believe nothing & trade 'em well!

GLTA

Jim trying to pump people again when he hasn’t done anything in 4 years.. other than sell on retail… and where did that money go?

It's very frustrating and he doesn't communicate. I just do not put much thought into it anymore. When someone continues to lie to people via phone, it becomes a big problem. Jim has to find another way to communicate and be more transparent. Seems too hard now.

Aqua, you probably know this business and process as well as, or more than anyone on the board. Is it as simple that Jim was handed a layup and just isn't able to get it done? I wouldn't consider it a scam, as the Italy trials show otherwise. Time to bring in a CEO who understands the process and can get this to the finish line. It appeared that Jim surrounded himself with knowledgeable people, but for whatever reason it's not progressing. Like you said, why can't Spivak's company, or someone else write a check to get the toxicology study completed. What about the wealthy people at that Florida conference Jim went to a couple years back when he said several people wanted to support the company's efforts. I don't know, maybe Jim spending too much time on VXIT. I would have thought GSTC was his golden goose, hugely disappointing to this point.

No one knows the exact number. But a small-scale toxicology study with animal N's of 16-32 is a big deal. Maybe for the companies hourly wage. Jim just doesnt communicate. So, we are left to speculate. Anyway, I will wait and just see what comes of it.

0007 average down again? come on JIM ....update us

recent filings show some loans I think at least 50k....could that be going to the toxicology study?

If it’s that cheap to do these things and no one is stepping up….this is a scam period and there’s nothing here

There are people well into the 6-figures here that are under water. And will go after Jim if he doesnt make something happen. Not holding my breath anymore because if Spivak cant loan Jim $50k for toxicology study, we are in terrible shape. That is all one needs to know. Just a complete farce. He provided no solid agreements. Just have to wait and see. I'm hoping someone with experience takes over, Jim leaves and keeps his shares, and we can start doing something. But the board has to kick him out, and right now they are not.

Exactly.. he doesn’t care about the people he hurt financially.

I stopped calling him a long time ago. The only information that I received that told me he was actually working on this was contacting Tim Coetzee for MS Society and contacting Mass General when Jim and group had a sit down with them. Which I got confirmations from. Those people are trust. Jim, clearly, lost a lot of peoples and shareholders trust a while ago. They updated the patent. I spoke to the Patent owner, Fabrizio, who says Jim just talks a lot. Clearly, Jim needs to be replaced. He doesn't care.

Aqua got lied to as well.. Jim just pumps people on the phone and doesn’t care

Jim is the reaper of otc.. destroying left and right

next update overdue from Jim...it hits this flies to 004 fast...LFG JIM....release the KRAKEN

come back aqua!
$GSTC---$GSTC Patent "Treatment of Multiple Sclerosis" by Inventor Fabrizio De Silvestre (US10610592B2). Original Expiration was 2027, now updated for exclusivity to 2035. #treatment #therapy #biotech #biotechnology #science #biology #fda #clinicaltrials https://t.co/VzlkwzcPhN pic.twitter.com/80hHn64se4— otcinfluencer (@mikeycolombia33) July 11, 2024

Last group isn’t happy with him. But hopefully new group helps before they try to expose him

a group gets hold of this and we are GOLDEN jackpot
900k market cap.....insane for a OTCQB

got more bids in as I'm loaded for next run....news overdue...when was the last news/8k?

we need news/8k...come on Jim...throw us a bone

he laughting at u peasants while this going to $1

Which you cannot do

He told many through phone and text…

how many you got left on ask 001?

This is the realest thing ever posted on this board

Sell it all

Does anyone have any visibility here? I am steadily selling as I dont believe they have anything of value here, just a lot of talk. The only good thing is that they seemed to always be able to file, albeit late sometimes.

How about...
"Do it for your community!!!!!!!!!!!!!!"
He can say that, right?

Can’t tell shareholders to grab cheap shares Jim

Mojo risin